EP
Eversept Partners’s Ascendis Pharma ASND Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-417,172
| Closed | -$49M | – | 70 |
|
|
2022
Q1 | $49M | Buy |
417,172
+13,494
| +3% | +$1.58M | 3.76% | 7 |
|
|
2021
Q4 | $54.3M | Sell |
403,678
-41,525
| -9% | -$5.59M | 3.47% | 6 |
|
|
2021
Q3 | $71M | Buy |
445,203
+203,429
| +84% | +$32.4M | 4.91% | 2 |
|
|
2021
Q2 | $31.8M | Sell |
241,774
-70,093
| -22% | -$9.22M | 2.12% | 12 |
|
|
2021
Q1 | $40.2M | Buy |
311,867
+124,824
| +67% | +$16.1M | 3.02% | 8 |
|
|
2020
Q4 | $31.2M | Buy |
187,043
+26,039
| +16% | +$4.34M | 3.66% | 9 |
|
|
2020
Q3 | $24.8M | Sell |
161,004
-59,340
| -27% | -$9.16M | 5.52% | 4 |
|
|
2020
Q2 | $32.6M | Sell |
220,344
-55,150
| -20% | -$8.16M | 4.47% | 5 |
|
|
2020
Q1 | $31M | Buy |
275,494
+72,600
| +36% | +$8.18M | 7.71% | 3 |
|
|
2019
Q4 | $28.2M | Sell |
202,894
-33,498
| -14% | -$4.66M | 4.98% | 4 |
|
|
2019
Q3 | $22.8M | Buy |
236,392
+99,995
| +73% | +$9.63M | 7.06% | 5 |
|
|
2019
Q2 | $15.7M | Buy |
136,397
+33,101
| +32% | +$3.81M | 4.4% | 8 |
|
|
2019
Q1 | $12.2M | Buy |
103,296
+88,042
| +577% | +$10.4M | 3.55% | 10 |
|
|
2018
Q4 | $956K | Sell |
15,254
-3,800
| -20% | -$238K | 0.52% | 34 |
|
|
2018
Q3 | $1.35M | Sell |
19,054
-11,000
| -37% | -$779K | 0.59% | 29 |
|
|
2018
Q2 | $2M | Buy |
30,054
+6,000
| +25% | +$399K | 0.91% | 25 |
|
|
2018
Q1 | $1.57M | Buy |
24,054
+11,936
| +98% | +$781K | 0.73% | 27 |
|
|
2017
Q4 | $485K | Buy |
+12,118
| New | +$485K | 0.28% | 36 |
|